DarioHealth Corp
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
DRIO$2.06-13.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| | | | | | | |
|---|---|---|---|---|---|---|
| · · December 31, | ||||||
| · · 2023 · 2022 | ||||||
| · · · · | ||||||
| ASSETS | | | | | | |
| | | | | | | |
| CURRENT ASSETS: · · · | ||||||
| Cash and cash equivalents | | $36,797 | | $49,357 | ||
| Short-term restricted bank deposits | | 292 | | 165 | ||
| Trade receivables, net | | 3,155 | | 6,416 | ||
| Inventories | | 5,062 | | 7,956 | ||
| Other accounts receivable and prepaid expenses | | 2,024 | | 1,630 | ||
| | | | | | | |
| Total current assets | | 47,330 | | 65,524 | ||
| | | | | | | |
| NON-CURRENT ASSETS: | | | | | ||
| Deposits | | | 6 | | | 6 |
| Operating lease right of use assets | | 967 | | 1,206 | ||
| Long-term assets | | | 143 | | | 111 |
| Property and equipment, net | | | 899 | | | 788 |
| Intangible assets, net | | | 5,404 | | | 9,916 |
| Goodwill | | | 41,640 | | | 41,640 |
| | | | | | | |
| Total non-current assets | | | 49,059 | | | 53,667 |
| | | | | | | |
| Total assets | | $96,389 | | $119,191 | ||
CONSOLIDATED BALANCE SHEETS
| | | | | | | |
|---|---|---|---|---|---|---|
| · · December 31, | ||||||
| | | 2023 | 2022 | |||
| | | | | | | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY · · · · | ||||||
| | | | | | | |
| CURRENT LIABILITIES: · · · | ||||||
| Trade payables | | $1,131 | | $2,322 | ||
| Deferred revenues | | 997 | | 1,320 | ||
| Operating lease liabilities | | | 111 | | | 293 |
| Other accounts payable and accrued expenses | | 6,300 | | 6,592 | ||
| Current maturity of long term loan | | | 3,954 | | | 8,823 |
| | | | | | | |
| Total current liabilities | | 12,493 | | 19,350 | ||
| | | | | | | |
| NON-CURRENT LIABILITIES | | | | | | |
| Operating lease liabilities | | 885 | | 827 | ||
| Long-term loan | | | 24,591 | | | 18,105 |
| Warrant liability | | 240 | | 910 | ||
| Other long-term liabilities | | 36 | | — | ||
| | | | | | | |
| Total non-current liabilities | | | 25,752 | | | 19,842 |
| | | | | | | |
| STOCKHOLDERS’ EQUITY | | | | | ||
| Common stock of $0.0001 par value - authorized: 160,000,000 shares; issued and outstanding: 27,191,849 and 25,724,470 shares on December 31, 2023 and December 31, 2022, respectively | | 3 | | 3 | ||
| Preferred stock of $0.0001 par value - authorized: 5,000,000 shares; issued and outstanding: 18,959 and 3,567 shares on December 31, 2023 and December 31, 2022, respectively | | *) - | | *) - | ||
| Additional paid-in capital | | 407,502 | | 365,846 | ||
| Accumulated deficit | | (349,361) | | (285,850) | ||
| | | | | | | |
| Total stockholders’ equity | | 58,144 | | 79,999 | ||
| | | | | | | |
| Total liabilities and stockholders’ equity | | $96,389 | | $119,191 | ||
*) Represents an amount lower than $1.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.